PBAC Public Summary Documents – July 2021
Page last updated: 25 May 2022
Public Summary Documents relating to the July 2021 PBAC meeting.
- Acalabrutinib: Capsule 100 mg; Calquence®
- Adalimumab: Injection 20 mg in 0.4 mL pre-filled syringe, Injection 40 mg in 0.8 mL pre-filled syringe, Injection 40 mg in 0.8 mL pre-filled pen; Abrilada®
- Amino acid formula with vitamins and minerals without methionine: Sachets containing oral powder 25 g, 30; HCU Express 15®
- Amino acid formula with vitamins and minerals without phenylalanine: Sachets containing oral powder 34 g, 30; PKU Express 20®
- Amino acid formula with vitamins and minerals without phenylalanine: Sachets containing oral powder 25 g,30; PKU Express 15®
- Amino acid formula with vitamins and minerals without phenylalanine and tyrosine: Sachets containing oral powder 25 g,30; TYR Express 15®
- Amino acid formula with vitamins and minerals without valine, leucine and isoleucine: Sachets containing oral powder 25 g, 30; MSUD Express 15®
- Baricitinib: Tablet 2 mg, Tablet 4 mg; Olumiant®
- Bortezomib: Powder for injection 1 mg, Powder for injection 2.5 mg, Powder for injection 3 mg, Powder for injection 3.5 mg: DBL Bortezomib®
- Bortezomib: Powder for injection 2.5 mg; Bortezomib Juno®
- Budesonide + glycopyrronium + formoterol: Pressurised inhalation containing budesonide 160 micrograms with glycopyrronium 7.2 micrograms (as bromide) and formoterol fumarate dihydrate 5 micrograms per dose, 120 doses; Breztri Aerosphere®
- Dapagliflozin (chronic kidney disease): Tablet 10 mg; Forxiga®
- Dapagliflozin (heart failure): Tablet 10 mg; Forxiga®
- Daratumumab: Solution for subcutaneous injection 1,800 mg in 15 mL vial; Darzalex®
- Darolutamide: Tablet 300 mg; Nubeqa®
- Decitabine with cedazuridine: Tablet containing decitabine 35 mg + cedazuridine 100 mg; Inqovi®
- Elexacaftor/tezacaftor/ ivacaftor and ivacaftor: Pack containing 56 tablets of elexacaftor 100 mg with tezacaftor 50 mg and ivacaftor 75 mg and 28 tablets of ivacaftor 150 mg; Trikafta®
- Elotuzumab: Powder for I.V. infusion 300 mg, Powder for I.V. infusion 400 mg; Empliciti®
- Enzalutamide and abiraterone: Enzalutamide: Capsule 40 mg; Xtandi®; Abiraterone: Tablet 500 mg, Tablet 250 mg; Zytiga®
- Esketamine: Nasal spray solution 28 mg; Spravato®
- Etanercept: Injection 50 mg in 1 mL single use dose-dispenser cartridge, 4; Enbrel®
- Follitropin alfa: Injection 300 I.U. in 0.5 mL multi-dose cartridge, Injection 450 I.U. in 0.75 mL multi-dose cartridge, Injection 900 I.U. in 1.5 mL multi-dose cartridge; Ovaleap®
- High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate: Oral liquid 250 mL, 30; KetoVie® Peptide 4:1
- Hydrocortisone: Capsule containing granules 0.5 mg, Capsule containing granules 1 mg, Capsule containing granules 2 mg, Capsule containing granules 5 mg; Alkindi®
- Hypromellose: Eye drops 3 mg per mL, 10 mL; Revive Tears®
- Lanadelumab: Solution for subcutaneous injection 300 mg in 2 mL; Takhzyro®
- Lumacaftor + ivacaftor: Tablet containing lumacaftor 100 mg with ivacaftor 125 mg; Orkambi®
- Melatonin: Tablet 1 mg, Tablet 5 mg; Slenyto®
- Methoxsalen: Solution for blood fraction 20 microgram per mL, 10 mL; Uvadex®
- Nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®
- Niraparib: Capsule 100 mg; Zejula®
- Nusinersen: Solution for injection 12.6 mg in 5 mL; Spinraza®
- Opicapone: Capsule 50 mg; Ongentys®
- Palbociclib: Tablet 75 mg, Tablet 100 mg, Tablet 125 mg; Ibrance®
- Ravulizumab: Solution concentrate for I.V. infusion 300 mg in 3 mL, Solution concentrate for I.V. infusion 1,100 mg in 11 mL; Ultomiris®
- Ripretinib: Tablet 50 mg; Qinlock®
- Secukinumab: Injection 150 mg in 1 mL pre-filled pen; Cosentyx®
- Selinexor (RRMM): Tablet 20 mg; Xpovio®
- Selinexor (TCR/PR MM): Tablet 20 mg; Xpovio®
- Siltuximab: Powder for injection 100 mg, Powder for injection 400 mg; Sylvant®
- Trabectedin: Powder for I.V. infusion 0.25 mg, Powder for I.V. infusion 1 mg; Yondelis®
- Triptorelin: Powder for I.M. injection (prolonged release) 22.5 mg (as embonate), with solvent; Diphereline®
- Upadacitinib: Tablet 15 mg, Tablet 30 mg; Rinvoq®
- Venetoclax: Tablet 50 mg, Tablet 100 mg: Venclexta®
- Zanubrutinib (RR MCL): Capsule 80 mg; Brukinsa®
- Zanubrutinib (WM): Capsule 80 mg; Brukinsa®
